Comments for: FDA seeks warnings on two diabetes drugs

FDA seeks warnings on two diabetes drugs
WASHINGTON – Federal health officials have moved to put the strongest warning labels on two diabetes drugs, including Avandia, whose possible side effects were the focus of a heated congressional hearing Wednesday accusing the government and drug maker of sitting on information about the health risks. Read More
      Read more

      You may also like

      By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.